32669846|t|Major Neurologic Adverse Drug Reactions, Potential Drug-Drug Interactions and Pharmacokinetic Aspects of Drugs Used in COVID-19 Patients with Stroke: A Narrative Review.
32669846|a|Stroke has been considered as one of the underlying diseases that increases the probability of severe infection and mortality. Meanwhile, there are ongoing reports of stroke subsequent to COVID-19 infection. In this narrative paper, we reviewed major neurologic adverse drug reactions (ADRs) and pharmacokinetics of drugs which are routinely used for COVID-19 infection and their potential drug-drug interactions (PDDIs) with common drugs used for the treatment of stroke. It is highly recommended to monitor patients on chloroquine (CQ), hydroxychloroquine (HCQ), antiviral drugs, and/or corticosteroids about initiation or progression of cardiac arrhythmias, delirium, seizure, myopathy, and/or neuropathy. In addition, PDDIs of anti-COVID-19 drugs with tissue plasminogen activator (tPA), anticoagulants, antiaggregants, statins, antihypertensive agents, and iodine-contrast agents should be considered. The most dangerous PDDIs were interaction of lopinavir/ritonavir or atazanavir with clopidogrel, prasugrel, and new oral anticoagulants (NOACs).
32669846	6	39	Neurologic Adverse Drug Reactions	Disease	MESH:D064420
32669846	51	60	Drug-Drug	Disease	MESH:D000081015
32669846	119	127	COVID-19	Disease	MESH:D000086382
32669846	128	136	Patients	Species	9606
32669846	142	148	Stroke	Disease	MESH:D020521
32669846	170	176	Stroke	Disease	MESH:D020521
32669846	272	281	infection	Disease	MESH:D007239
32669846	337	343	stroke	Disease	MESH:D020521
32669846	358	376	COVID-19 infection	Disease	MESH:D000086382
32669846	421	454	neurologic adverse drug reactions	Disease	MESH:D064420
32669846	521	539	COVID-19 infection	Disease	MESH:D000086382
32669846	560	569	drug-drug	Disease	MESH:D000081015
32669846	635	641	stroke	Disease	MESH:D020521
32669846	679	687	patients	Species	9606
32669846	691	702	chloroquine	Chemical	MESH:D002738
32669846	704	706	CQ	Chemical	MESH:D002738
32669846	709	727	hydroxychloroquine	Chemical	MESH:D006886
32669846	729	732	HCQ	Chemical	MESH:D006886
32669846	810	829	cardiac arrhythmias	Disease	MESH:D001145
32669846	831	839	delirium	Disease	MESH:D003693
32669846	841	848	seizure	Disease	MESH:D012640
32669846	850	858	myopathy	Disease	MESH:D009135
32669846	867	877	neuropathy	Disease	MESH:D009422
32669846	901	920	anti-COVID-19 drugs	Chemical	-
32669846	926	954	tissue plasminogen activator	Gene	5327
32669846	956	959	tPA	Gene	5327
32669846	1032	1054	iodine-contrast agents	Chemical	-
32669846	1122	1141	lopinavir/ritonavir	Chemical	MESH:C558899
32669846	1145	1155	atazanavir	Chemical	MESH:D000069446
32669846	1161	1172	clopidogrel	Chemical	MESH:D000077144
32669846	1174	1183	prasugrel	Chemical	MESH:D000068799
32669846	1189	1212	new oral anticoagulants	Chemical	-
32669846	1214	1219	NOACs	Chemical	-
32669846	Association	MESH:D000068799	MESH:D000069446
32669846	Positive_Correlation	MESH:D006886	MESH:D001145
32669846	Association	MESH:C558899	MESH:D000077144
32669846	Positive_Correlation	MESH:D002738	MESH:D009135
32669846	Positive_Correlation	MESH:D002738	MESH:D001145
32669846	Positive_Correlation	MESH:D006886	MESH:D009422
32669846	Positive_Correlation	MESH:D002738	MESH:D003693
32669846	Association	MESH:D000069446	MESH:D000077144
32669846	Positive_Correlation	MESH:D006886	MESH:D009135
32669846	Positive_Correlation	MESH:D006886	MESH:D003693
32669846	Positive_Correlation	MESH:D002738	MESH:D012640
32669846	Association	MESH:C558899	MESH:D000068799
32669846	Positive_Correlation	MESH:D002738	MESH:D009422
32669846	Positive_Correlation	MESH:D006886	MESH:D012640

